Patient Safety Topics

This program will expire and must be completed by 03/29/26.

*** Please note this classroom webinar was part of the KCU Homecoming 2022. If you participated in the live event, you would not want to choose this program. ***

This is a bundle of three programs from the 2022 KCU Homecoming. The descriptions and objectives of these programs are listed below.

Medical Marijuana: Potential Benefits & Future Directions

This presentation will include the historical background, epidemiology, and mechanism of action of Cannabis. It will also cover current FDA-approved indications for Cannabis and future research and potential benefits of medical cannabis.

Learning Objectives:

• Understand the historical use of cannabis and current regulations around the use of  medical cannabis
• Describe the neurobiology and epidemiology of cannabis
• Discuss routes of administration, pharmacodynamics, and physiological effects of cannabis
• Understand future areas of research for medical cannabis

Patient Safety & Infection: Choices of Life-Sustaining Treatment & Potential Outcomes

Dying is a universal experience every human being must contemplate. Therefore, every physician must be prepared to advise and deal with the ethical dilemmas of the dying process. Considering the medical education curriculum writ large, this topic is not always presented in sufficient detail. Therefore all physicians should strive to become more familiar with these issues and their implications.

Learning Objectives:

• The participant will be able to name two ethical dilemma situations that commonly occur.
• The participant will be able to access educational materials provided in the presentation for future reference.
• The participant will be able to explain the physician's role in end-of-life situations.

Safe Prescribing for Pain, Depression, & Anxiety

This presentation will focus on key safety considerations for pain, depression, and anxiety medication management in the primary care setting. The pain management section will provide information about buprenorphine and cannabis and review basic safety guidelines. The depression segment will focus on diagnostic accuracy and suicide risk and explain the use of recommended atypical antipsychotics. The anxiety section will focus on the detriments of long-term treatment with benzodiazepines and recommend safer alternatives. 

Learning Objectives:

• New harm reduction ideas for pain management
• Identify potential pitfalls of depression treatment
• Review salient safety concerns about anxiety medications

Accreditation Statement:
The event has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) and the American Osteopathic Association (AOA) through the joint providership of the Missouri Association of Osteopathic Physicians and Surgeons (MAOPS) and Kansas City University (KCU) College of Osteopathic Medicine. MAOPS is accredited by the ACCME to provide continuing medical education for physicians.

AMA (Allopathic) Credit Designation:
MAOPS is accredited by the ACCME to provide continuing medical education for physicians. MAOPS designates this activity for a maximum of 2.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AOA (Osteopathic) Credit Designation:
MAOPS is accredited by the AOA to provide osteopathic continuing medical education for physicians. MAOPS designates this program for a maximum of 2.75 AOA Category 1-A CME Credit(s) and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.

Planning Committee:
The KCU CME Committee members serve as the CME Planning Committee for this conference. Membership of the committee includes faculty and staff from KCU and may include physicians from local communities. Members of the committee are listed on the KCU CME webpage at https://www.kansascity.edu/programs/continuing-medical-education.

Disclosures:
Each of the members of the Conference Planning Committee discloses that the relevant parties have no actual or potential conflict of interest in relation to this program or presentation, including no relevant financial relationships with any commercial interests relative to the content of this program. Speaker disclosures are included within each bio and will be shown at the beginning of each presentation.

Grievance Policy for AOA Credit:
All grievances should be in writing and should specify the nature of the grievance. Initially, all grievances should be directed to MAOPS Executive Director, who will then forward said grievance to the Education & Convention Committee. All grievances will receive an initial response in writing within 30 days of receipt.  If the participant does not receive a satisfactory response, they can submit a complaint in writing to the Council on Continuing Medical Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.